Written Question · S2W-18320 · Session 2
What the main outcomes of the Cancer Challenge pilot screening programme were.
The question
To ask the Scottish Executive what the main outcomes of the Cancer Challenge pilot screening programme were.
The answer
The Department of Health commissioned a team from Edinburgh, Warwick and Essex Universities to formally evaluate the Cancer Challenge screening pilot which ran in England and Scotland from April 2000 to December 2002. The target UK population was approximately 300,000 over the screening period.
The following key outcomes are collated from the formal evaluation report submitted to the Department of Health in 2003 (this can be viewed online at http://www.cancerscreening.nhs.uk/bowel/finalreport.pdf) and also further statistical analysis of the complete dataset by NHS Information Services Division.
Screening for bowel cancer with faecal occult blood test (FOBt) kits in the general population is feasible and should be rolled out to a national programme.
Overall uptake of screening in Scotland was 50.4% for males, 59.5% for females and 55% overall.
Greater number of early stage cancers detected in the population being screened compared to the population that have not been screened (Dukes A: screened population 22.5%, non-screened population 12.6%).
Uptake rates influenced by deprivation (Both sexes: least deprived 62.1% compared to most deprived 41.2% by Scottish Index of Multiple Deprivation).
UK pilot had a considerable impact on workload in secondary care including increased demand for non-screening colonoscopy services and a substantial impact on pathology services.
The impact on primary care was modest.
Systematic review indicates that FOBt screening costs approximately £2,000 per Quality Adjusted Life Year and appears relatively cost effective – at this level FOBt screening is well within arbitrary “efficiency” thresholds and commensurate with other population based cancer screening programmes.
The following key outcomes are collated from the formal evaluation report submitted to the Department of Health in 2003 (this can be viewed online at http://www.cancerscreening.nhs.uk/bowel/finalreport.pdf) and also further statistical analysis of the complete dataset by NHS Information Services Division.
Screening for bowel cancer with faecal occult blood test (FOBt) kits in the general population is feasible and should be rolled out to a national programme.
Overall uptake of screening in Scotland was 50.4% for males, 59.5% for females and 55% overall.
Greater number of early stage cancers detected in the population being screened compared to the population that have not been screened (Dukes A: screened population 22.5%, non-screened population 12.6%).
Uptake rates influenced by deprivation (Both sexes: least deprived 62.1% compared to most deprived 41.2% by Scottish Index of Multiple Deprivation).
UK pilot had a considerable impact on workload in secondary care including increased demand for non-screening colonoscopy services and a substantial impact on pathology services.
The impact on primary care was modest.
Systematic review indicates that FOBt screening costs approximately £2,000 per Quality Adjusted Life Year and appears relatively cost effective – at this level FOBt screening is well within arbitrary “efficiency” thresholds and commensurate with other population based cancer screening programmes.
In the Official Report
No contribution in the Official Report cites S2W-18320 by reference.